TDI01
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Beijing Tide Pharmaceutical Co., Ltd
Overview
TDI01 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
TDI01 clinical trials
Explore related
Medical disclaimer. This page summarizes research about TDI01 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.